InsidersTradesSigma
Follow the Devyser Diagnostics AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Devyser Diagnostics AB has published 0 public disclosures. Market capitalisation: €1.1bn. The full history is openly available.
Analysts rate Devyser Diagnostics AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 96.47.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
Devyser Diagnostics AB is a company focused on developing molecular diagnostic tests for genetic diseases. It is listed on the Stockholm Stock Exchange (XSTO).